ArticleClinicoEconomics and outcomes research : CEOR2026
Social Impact and Economic Burden of Uncoded Hyponatremia in Elderly - A Cost-of-Illness Study.
Article in ClinicoEconomics and outcomes research : CEOR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Hyponatremia remains one of the most prevalent electrolyte disorders among geriatric inpatients but is frequently under-recognized in clinical coding. This Patients and Methods: A retrospective Results: Among 13,657 patients with hyponatremia (18.7%), only 2,070 (2.8%) were coded. Prevalences were as follows: coded 2.8%, hidden15.9%, true prevalence 18.7%. ucHn was more prevalent in men (p<0.0001), presented with more mild cases (83.1/34.9%, p<0.0001), more incident cases (14.3/4.7%, p<0.0001), lower chronic hyponatremia (20.8/39.6% p<0.0001), significantly more frequent heart failure and lung cancer (p<0.0001), had higher asset cost (2,463 vs 1,654, p<0.0001), lower contribution margin 1 and 2 (p<0.0001) and a markedly higher 30-day mortality (46% vs 7%, p<0.0001). Mean length of stay (LOS) was 9.9 days vs 7.4 days (p<0.0001). ucHn generated incremental costs of CHF per case with a total systemic burden (2016-2024) amounted to ≈ 355 to 473 MCHF. Losses of autonomy, mobility, cognitive control and life years underline the impressive social impact for nearly every ucHn case. Conclusion: For the first time, the detected ucHn is evaluated. It presents a substantial social and economic burden with a previously unquantified excess mortality associated with uncoded hyponatremia. ucHn is widely underestimated in administrative hospital data. This COI study supports policy measures to improve documentation and awareness of hyponatremia in elderly patients with the aim of reducing its social impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.